These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33946049)
1. Aging-related genes are potential prognostic biomarkers for patients with gliomas. Xiao G; Zhang X; Zhang X; Chen Y; Xia Z; Cao H; Huang J; Cheng Q Aging (Albany NY); 2021 May; 13(9):13239-13263. PubMed ID: 33946049 [TBL] [Abstract][Full Text] [Related]
2. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma. Luo H; Tao C; Long X; Huang K; Zhu X Aging (Albany NY); 2021 Jun; 13(12):16198-16218. PubMed ID: 34114970 [TBL] [Abstract][Full Text] [Related]
3. Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients. Peng Z; Chen Y; Cao H; Zou H; Wan X; Zeng W; Liu Y; Hu J; Zhang N; Xia Z; Liu Z; Cheng Q Aging (Albany NY); 2020 Feb; 12(3):2347-2372. PubMed ID: 32023222 [TBL] [Abstract][Full Text] [Related]
4. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas. Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811 [TBL] [Abstract][Full Text] [Related]
5. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas. Coppola D; Balducci L; Chen DT; Loboda A; Nebozhyn M; Staller A; Fulp WJ; Dalton W; Yeatman T; Brem S J Geriatr Oncol; 2014 Oct; 5(4):389-99. PubMed ID: 25220188 [TBL] [Abstract][Full Text] [Related]
6. RAB34 was a progression- and prognosis-associated biomarker in gliomas. Wang HJ; Gao Y; Chen L; Li YL; Jiang CL Tumour Biol; 2015 Mar; 36(3):1573-8. PubMed ID: 25501506 [TBL] [Abstract][Full Text] [Related]
7. Identification of Critical m Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046 [TBL] [Abstract][Full Text] [Related]
8. Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas. Hu Q; Huang K; Tao C; Zhu X J Cell Mol Med; 2020 May; 24(10):5888-5900. PubMed ID: 32301283 [TBL] [Abstract][Full Text] [Related]
9. Cell aging related genes can be used to characterize clinical prognoses and further stratify diffuse gliomas. Yang Y; Chen X; Sun J; Chen S; Yang C; Ma Q; Yang J Sci Rep; 2021 Sep; 11(1):19493. PubMed ID: 34593910 [TBL] [Abstract][Full Text] [Related]
10. Top-down stepwise refinement identifies coding and noncoding RNA-associated epigenetic regulatory maps in malignant glioma. Huang Y; Gao X; Yang E; Yue K; Cao Y; Zhao B; Zhang H; Dai S; Zhang L; Luo P; Jiang X J Cell Mol Med; 2022 Apr; 26(8):2230-2250. PubMed ID: 35194922 [TBL] [Abstract][Full Text] [Related]
11. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas. Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572 [TBL] [Abstract][Full Text] [Related]
12. Identification of a mesenchymal-related signature associated with clinical prognosis in glioma. Zhang Z; Chen J; Huo X; Zong G; Huang K; Cheng M; Sun L; Yue X; Bian E; Zhao B Aging (Albany NY); 2021 Apr; 13(9):12431-12455. PubMed ID: 33875619 [TBL] [Abstract][Full Text] [Related]
13. Endothelin B receptor promotes the proliferation and immune escape of malignant gliomas. Pan DS; Feng SZ; Cao P; Li JJ Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1230-1235. PubMed ID: 28841806 [TBL] [Abstract][Full Text] [Related]
14. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling. Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
17. Identification of PIEZO1 as a potential prognostic marker in gliomas. Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349 [TBL] [Abstract][Full Text] [Related]
18. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
19. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566 [TBL] [Abstract][Full Text] [Related]
20. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]